logo
15:55 Mar 13

Piramal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
201.84
+0.02 (+0.01%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Piramal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:55 Mar 13
Up
201.84
+0.02 (+0.01%)
image/svg+xml

80/100 High Financial Strength

Quality
image/svg+xml

22/100 Expensive Valuation

Valuation

48/100 Technically Neutral

Technical

SWOT

Strength

5

Weakness

3

Opportunity

2

Threat

0

26.76K

Market Cap (Cr)

687.89

PE Ratio

3.38

Price to Book Ratio

44.91

RSI

0.21 %

Net Profit Margin

Rating Based on 6 Analysts

Buy 100%
Hold 0%
Sell 0%
Buy
The consensus recommendation from 6 analysts for Piramal Pharma Ltd. is Buy

Analyst Price Target

The average price target is 249.5 with a high estimate of 310 and low estimate of 176
Current 201.84
310.00
249.50
176.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
  • Profit making Companies with High ROCE and Low PE
  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth
  • Strong QoQ EPS Growth in recent results
  • Companies with rising net profit margins - quarterly as well as TTM basis
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Increasing profits every quarter for the past 2 quarters
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge
  • Stock with Low PE (PE < = 10)
  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
  • Profit making Companies with High ROCE and Low PE
  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth
  • Strong QoQ EPS Growth in recent results
  • Companies with rising net profit margins - quarterly as well as TTM basis
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Increasing profits every quarter for the past 2 quarters
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge
  • Stock with Low PE (PE < = 10)
qr-code
login-icon

Take your research to the next level.
Login now to unlock Exclusive Features!

login-icon-1

Take your research to the next level.
Login now to unlock Exclusive Features!

Research 360 logo

Download Our App On:

SunMonTueWedThuFriSat
2627282930311234567891011121314151617181920212223242526272829303112345